Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development
The spike protein of coronavirus is key target for drug development and other pharmacological interventions. In current study, we performed an integra…
www.sciencedirect.com
View: https://twitter.com/BidoliNicola/status/1455508366097268737